IL160000A0 - Methods, compositions and kits relating to chitinases and chitinase-like molecules and imflammatory disease - Google Patents
Methods, compositions and kits relating to chitinases and chitinase-like molecules and imflammatory diseaseInfo
- Publication number
- IL160000A0 IL160000A0 IL16000002A IL16000002A IL160000A0 IL 160000 A0 IL160000 A0 IL 160000A0 IL 16000002 A IL16000002 A IL 16000002A IL 16000002 A IL16000002 A IL 16000002A IL 160000 A0 IL160000 A0 IL 160000A0
- Authority
- IL
- Israel
- Prior art keywords
- chitinases
- chitinase
- molecules
- compositions
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
- C12N9/2442—Chitinase (3.2.1.14)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01014—Chitinase (3.2.1.14)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/77—Internalization into the cell
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/81—Drug, bio-affecting and body treating compositions involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30743201P | 2001-07-24 | 2001-07-24 | |
PCT/US2002/023516 WO2003009808A2 (en) | 2001-07-24 | 2002-07-23 | Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
Publications (1)
Publication Number | Publication Date |
---|---|
IL160000A0 true IL160000A0 (en) | 2004-06-20 |
Family
ID=23189747
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16000002A IL160000A0 (en) | 2001-07-24 | 2002-07-23 | Methods, compositions and kits relating to chitinases and chitinase-like molecules and imflammatory disease |
IL160000A IL160000A (en) | 2001-07-24 | 2004-01-22 | Chitinase-binding antibodies to treat asthma |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL160000A IL160000A (en) | 2001-07-24 | 2004-01-22 | Chitinase-binding antibodies to treat asthma |
Country Status (13)
Country | Link |
---|---|
US (6) | US7214373B2 (xx) |
EP (1) | EP1418813A4 (xx) |
JP (1) | JP2006508014A (xx) |
KR (1) | KR20040053100A (xx) |
AU (1) | AU2002319680B2 (xx) |
BR (1) | BR0211468A (xx) |
CA (1) | CA2454342A1 (xx) |
HU (1) | HUP0400659A3 (xx) |
IL (2) | IL160000A0 (xx) |
MX (1) | MXPA04000769A (xx) |
NO (1) | NO20040330L (xx) |
PL (1) | PL369010A1 (xx) |
WO (1) | WO2003009808A2 (xx) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003031582A2 (en) * | 2001-10-09 | 2003-04-17 | Genentech, Inc. | Novel acidic mammalian proteins and polynucleotides encoding the same |
US20040170621A1 (en) * | 2002-08-30 | 2004-09-02 | Roodman G. David | Method of resisting osteoclast formation |
US7364846B2 (en) * | 2002-10-11 | 2008-04-29 | Molecular Devices Corporation | Gene expression profiling from FFPE samples |
WO2004092404A2 (en) * | 2003-04-11 | 2004-10-28 | Wyeth | Inhibitors of acidic mammalian chitinase as asthma therapeutics |
WO2005081980A2 (en) * | 2004-02-25 | 2005-09-09 | Medimmune, Inc. | Methods and compositions relating to chitinases and chitinase-like molecules and modulation of osteoclasts |
WO2007002543A2 (en) | 2005-06-23 | 2007-01-04 | Medimmune, Inc. | Antibody formulations having optimized aggregation and fragmentation profiles |
EP1928496A4 (en) * | 2005-08-31 | 2011-01-05 | Medimmune Inc | C / CLP ANTAGONISTS AND METHOD OF USE |
TW200813091A (en) | 2006-04-10 | 2008-03-16 | Amgen Fremont Inc | Targeted binding agents directed to uPAR and uses thereof |
WO2008144646A1 (en) * | 2007-05-18 | 2008-11-27 | Wyeth | Novel primate chitinases and uses therefor |
NZ586746A (en) * | 2008-01-23 | 2012-07-27 | Righospitalet | Classification of individuals suffering from cardiovascular diseases according to survival prognoses as found by measuring the levels of biomarker ykl-40 |
EP2245459A1 (en) | 2008-01-23 | 2010-11-03 | Herlev Hospital | Ykl-40 as a general marker for non-specific disease |
JP5687194B2 (ja) | 2008-08-01 | 2015-03-18 | サイモン フレイザー ユニバーシティ | 選択的グリコシダーゼインヒビターおよびその使用 |
AU2009285550B2 (en) * | 2008-08-28 | 2015-06-18 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
CA2735590A1 (en) * | 2008-08-29 | 2010-03-04 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
EP2340437A1 (en) | 2008-09-15 | 2011-07-06 | Herlev Hospital | Ykl-40 as a marker for gastrointestinal cancers |
US20110207161A1 (en) * | 2008-10-21 | 2011-08-25 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
CN102246035B (zh) * | 2008-10-21 | 2014-10-22 | 阿斯图特医药公司 | 用于诊断和预后肾损伤和肾衰竭的方法和组合物 |
EP2361018B1 (en) | 2008-11-10 | 2015-04-01 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
CA2743253A1 (en) * | 2008-11-22 | 2010-05-27 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
US7851616B2 (en) * | 2008-12-04 | 2010-12-14 | Mingchi University Of Technology | Development of asthma therapy with rAAV-mediated AMCase shRNA |
US9229010B2 (en) | 2009-02-06 | 2016-01-05 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
BR112012002711A2 (pt) | 2009-08-07 | 2016-11-01 | Astute Medical Inc | metodo para avaliar o estado renal em um individuo, e, medicao de proteina |
JP2013510322A (ja) | 2009-11-07 | 2013-03-21 | アスチュート メディカル,インコーポレイテッド | 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物 |
KR20120123056A (ko) | 2009-12-20 | 2012-11-07 | 아스튜트 메디컬 인코포레이티드 | 신손상 및 신부전을 진단 및 예측하는 방법 및 조성물 |
HUE029304T2 (en) | 2010-02-05 | 2017-02-28 | Astute Medical Inc | Procedures and Preparations for Diagnosing and Predicting Kidney Damage and Kidney Failure |
EP3070474A3 (en) | 2010-02-26 | 2016-12-07 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
IN2012MN02812A (xx) | 2010-06-23 | 2015-05-22 | Astute Medical Inc | |
EP3339860A1 (en) | 2010-06-23 | 2018-06-27 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
NZ612703A (en) | 2010-12-23 | 2015-07-31 | Merck Sharp & Dohme | Selective glycosidase inhibitors and uses thereof |
EP2691407B1 (en) | 2011-03-31 | 2017-02-22 | Alectos Therapeutics Inc. | Selective glycosidase inhibitors and uses thereof |
US9701693B2 (en) | 2011-06-27 | 2017-07-11 | Alectos Therapeutics Inc. | Selective glycosidase inhibitors and uses thereof |
US10935548B2 (en) | 2011-12-08 | 2021-03-02 | Astute Medical, Inc. | Methods for diagnosis and prognosis of renal injury and renal failure using insulin-like growth factor-binding protein 7 and metalloproteinase inhibitor 2 |
AU2013226184A1 (en) * | 2012-02-27 | 2014-09-18 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
EP2890676B1 (en) | 2012-08-31 | 2018-12-05 | Alectos Therapeutics Inc. | Glycosidase inhibitors and uses thereof |
WO2014032188A1 (en) | 2012-08-31 | 2014-03-06 | Alectos Therapeutics Inc. | Glycosidase inhibitors and uses thereof |
WO2014067003A1 (en) | 2012-10-31 | 2014-05-08 | Alectos Therapeutics Inc. | Glycosidase inhibitors and uses thereof |
CN105074466B (zh) | 2013-01-17 | 2018-01-09 | 阿斯图特医药公司 | 用于肾损伤和肾衰竭的诊断及预后的方法和组合物 |
GB2521675B (en) | 2013-12-31 | 2015-11-11 | Houman Taheri Amlashi | Generating electricity |
WO2016063901A1 (ja) * | 2014-10-22 | 2016-04-28 | サントリーホールディングス株式会社 | 環状ジペプチドを有効成分とする皮膚保湿機能改善剤 |
ES2943579T3 (es) | 2014-12-18 | 2023-06-14 | Astute Medical Inc | Procedimientos y composiciones para el diagnóstico y pronóstico de lesión renal e insuficiencia renal |
WO2016136991A1 (ja) * | 2015-02-27 | 2016-09-01 | 味の素株式会社 | 唾液中マーカータンパク質を用いた低栄養状態の判定方法、及びそれに使用する診断薬 |
AU2017277305A1 (en) | 2016-06-06 | 2018-12-20 | Astute Medical, Inc. | Management of acute kidney injury using insulin-like growth factor-binding protein 7 and tissue inhibitor of metalloproteinase 2 |
WO2019036566A1 (en) | 2017-08-17 | 2019-02-21 | Brown University | METHODS AND COMPOSITIONS RELATING TO THE TREATMENT OF FIBROSIS |
JP7267562B2 (ja) * | 2018-05-21 | 2023-05-02 | 学校法人東京薬科大学 | 免疫調節作用を有する単球およびその使用方法 |
CN108926708A (zh) * | 2018-07-31 | 2018-12-04 | 张家港市第人民医院 | 过敏性鼻炎小鼠模型复制方法及应用 |
WO2021203051A1 (en) * | 2020-04-03 | 2021-10-07 | Standard Of Care Corporation | Aerosolized hyaluronidase and/or 4-methylumbelliferone compositions and methods of using same to treat respiratory diseases or disorders |
WO2024073612A2 (en) * | 2022-09-30 | 2024-04-04 | Cedars-Sinai Medical Center | Therapeutic nucleic acids and methods of use thereof |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69010388T2 (de) * | 1989-04-27 | 1994-10-20 | Ajinomoto Kk | Demethylallosamidin und ein Verfahren zu seiner Herstellung. |
JP3063930B2 (ja) | 1991-01-31 | 2000-07-12 | 味の素株式会社 | アロサミジン化合物及びその製造法 |
AU7205894A (en) * | 1993-06-08 | 1995-01-03 | Neogenix, Inc. | Purified natural and synthetic compounds for the treatment of osteoarthritis |
CA2164498C (en) | 1993-07-09 | 2007-09-11 | Paul A. Price | Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices |
US7229770B1 (en) * | 1998-10-01 | 2007-06-12 | The Regents Of The University Of California | YKL-40 as a marker and prognostic indicator for cancers |
IL115744A (en) | 1994-10-27 | 2000-07-16 | Akzo Nobel Nv | Peptides comprising a subsequence of human cartilage glycoprotein - 39 |
JP3634891B2 (ja) | 1995-04-06 | 2005-03-30 | 株式会社海洋バイオテクノロジー研究所 | キチナーゼ阻害物質 |
US5773259A (en) * | 1996-03-20 | 1998-06-30 | Smithkline Beecham Corporation | Tissue remodeling proteins |
US5843449A (en) | 1996-03-25 | 1998-12-01 | Akzo Nobel N.V. | Proteins and novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases |
EP0828752A4 (en) | 1996-03-29 | 2000-07-26 | Smithkline Beecham Corp | CHITOTRIOSIDASE |
EP0805206A3 (en) * | 1996-05-03 | 1999-09-15 | Smithkline Beecham Corporation | Human cartilage glycoprotein |
US5811535A (en) * | 1996-08-09 | 1998-09-22 | Smithkline Beecham Corporation | Human cartilege gp39-like gene |
IL122233A (en) * | 1996-12-06 | 2001-04-30 | Akzo Nobel Nv | Method of generating monoclonal antibodies to cell wall and pharmaceutical preparations and diagnostic agents containing them |
US6200951B1 (en) | 1998-03-12 | 2001-03-13 | Icos Corporation | Chitinase chitin-binding fragments |
US6060590A (en) * | 1998-03-31 | 2000-05-09 | The Regents Of The University Of California | Chitinase related proteins and methods of use |
WO2000004917A2 (en) | 1998-07-23 | 2000-02-03 | Akzo Nobel N.V. | USE OF HC gp-39 IN IMMUNE DISEASES |
CZ2001286A3 (en) | 1998-07-23 | 2001-08-15 | Akzo Nobel Nv | Use of isolated DNA or RNA molecule, viral vector and process for preparing thereof |
JP2000327575A (ja) | 1999-05-26 | 2000-11-28 | Teika Seiyaku Kk | ジケトピペラジン誘導体含有炎症疾患治療剤および新規なジケトピペラジン誘導体 |
AU1309601A (en) * | 1999-11-15 | 2001-05-30 | Takeda Chemical Industries Ltd. | Novel protein and dna thereof |
EP1319184B1 (en) | 2000-08-14 | 2007-07-25 | N.V. Organon | Use of antibodies against specific mhc-peptide complexes |
AU2001283327A1 (en) * | 2000-08-14 | 2002-02-25 | Human Genome Sciences, Inc. | 8 human secreted proteins |
DE10046267A1 (de) | 2000-09-19 | 2002-03-28 | Bayer Ag | Verwendung von Riboflavin und Flavinderivaten als Inhibitoren von Chitinasen |
US20030087414A1 (en) * | 2001-11-02 | 2003-05-08 | Aerts Johannes Maria Franciscus Gerardus | Mammalian mucinase, its recombinant production, and its use in therapy or prophylaxis against diseases in which mucus is involved or infectious diseases |
US20040170621A1 (en) * | 2002-08-30 | 2004-09-02 | Roodman G. David | Method of resisting osteoclast formation |
DE602006019205D1 (de) | 2005-02-28 | 2011-02-10 | Bio Y As | Monoklonale ykl-40-antikörper |
-
2002
- 2002-07-23 CA CA002454342A patent/CA2454342A1/en not_active Abandoned
- 2002-07-23 IL IL16000002A patent/IL160000A0/xx unknown
- 2002-07-23 AU AU2002319680A patent/AU2002319680B2/en not_active Ceased
- 2002-07-23 WO PCT/US2002/023516 patent/WO2003009808A2/en active Application Filing
- 2002-07-23 HU HU0400659A patent/HUP0400659A3/hu unknown
- 2002-07-23 MX MXPA04000769A patent/MXPA04000769A/es unknown
- 2002-07-23 KR KR10-2004-7001099A patent/KR20040053100A/ko not_active Application Discontinuation
- 2002-07-23 US US10/202,436 patent/US7214373B2/en not_active Expired - Lifetime
- 2002-07-23 JP JP2003515201A patent/JP2006508014A/ja not_active Withdrawn
- 2002-07-23 PL PL02369010A patent/PL369010A1/xx not_active Application Discontinuation
- 2002-07-23 EP EP02750284A patent/EP1418813A4/en not_active Withdrawn
- 2002-07-23 BR BR0211468-2A patent/BR0211468A/pt not_active IP Right Cessation
-
2004
- 2004-01-22 IL IL160000A patent/IL160000A/en not_active IP Right Cessation
- 2004-01-23 NO NO20040330A patent/NO20040330L/no not_active Application Discontinuation
- 2004-11-03 US US10/980,354 patent/US20060063728A1/en not_active Abandoned
-
2008
- 2008-07-18 US US12/218,836 patent/US20090149410A1/en not_active Abandoned
- 2008-07-18 US US12/218,840 patent/US20090148539A1/en not_active Abandoned
- 2008-11-21 US US12/275,737 patent/US20090162347A1/en not_active Abandoned
-
2010
- 2010-07-12 US US12/834,650 patent/US8679503B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
MXPA04000769A (es) | 2005-09-21 |
US20030049261A1 (en) | 2003-03-13 |
EP1418813A2 (en) | 2004-05-19 |
KR20040053100A (ko) | 2004-06-23 |
HUP0400659A2 (hu) | 2005-02-28 |
WO2003009808A2 (en) | 2003-02-06 |
US20060063728A1 (en) | 2006-03-23 |
US20090148539A1 (en) | 2009-06-11 |
JP2006508014A (ja) | 2006-03-09 |
BR0211468A (pt) | 2004-11-23 |
US20090162347A1 (en) | 2009-06-25 |
IL160000A (en) | 2010-06-16 |
WO2003009808A3 (en) | 2003-09-04 |
HUP0400659A3 (en) | 2005-06-28 |
US7214373B2 (en) | 2007-05-08 |
NO20040330L (no) | 2004-03-09 |
US20090149410A1 (en) | 2009-06-11 |
CA2454342A1 (en) | 2003-02-06 |
AU2002319680B2 (en) | 2008-04-10 |
US20130136751A1 (en) | 2013-05-30 |
US8679503B2 (en) | 2014-03-25 |
PL369010A1 (en) | 2005-04-18 |
EP1418813A4 (en) | 2009-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL160000A0 (en) | Methods, compositions and kits relating to chitinases and chitinase-like molecules and imflammatory disease | |
FI20021772A (fi) | Uudet hiilihydraattikoostumukset ja menetelmä niiden valmistamiseksi | |
EP1692318A4 (en) | COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF LUNG CANCER | |
EE200500011A (et) | Indasoolid, bensotiasoolid ja bensoisotiasoolid, nende valmistamine ning kasutamine | |
AU2001268126A1 (en) | Compositions, kits, and methods for promoting defined health benefits | |
EP1550674A4 (en) | POLYSACCHARIDE CONTAINING CHITOSAN, METHOD FOR PRODUCING THE SAME AND USE THEREOF | |
IL175472A0 (en) | Glucoimidazole and polyhydroxycyclohexenyl amine derivatives to treat gaucher disease | |
WO2005046434A8 (en) | Compositions and methods for diagnosing and treating mental disorders | |
MXPA05011522A (es) | Derivados de 2-acilamino-4-feniltiazol, metodo para su preparacion y su aplicacion en terapeutica. | |
EP1797020A4 (en) | GUANIDINE POLYSACCHARIDES, THEIR USE AS ABSORBENTS AND PROCESS FOR THE PRODUCTION THEREOF | |
BRPI0608802A2 (pt) | composto, agente para combater fungos nocivos, processo para combater fungos nocivos fitopatogênicos, uso de compostos e, semente | |
WO2005079396A3 (en) | O,o'-amidomalonate and n,o-amidomalonate platinum complexes | |
ATE464038T1 (de) | Topische anwendung mindestens eines doppelsträngigen rna-oligonucleotids (ds rna) gegen tyrosinase | |
EP1613269A4 (en) | COMPOSITIONS, METHODS AND KITS RELATING TO CLEARING HER-2 | |
ZA200711041B (en) | Topical pain relief compositions of N,2,3-trimethyl-2-isopropylbutamide and methods for using the same | |
AU2001268232A1 (en) | Compositions, methods, and kits relating to resistin-like molecules | |
PL1641342T3 (pl) | Homogeniczne ciekłe kompozycje zawierające sacharyd i olej | |
ZA200508655B (en) | Compositions and methods relating to stop-1 | |
EP1628993A4 (en) | METHOD AND COMPOSITIONS FOR RNA INTERFERENCE | |
IL161039A0 (en) | Mupirocin compositions for topical use, and improved process of making same and methods of using same | |
WO2003012051A8 (en) | Inhibitor of dna methylation | |
EE200300060A (et) | Polaarsete rühmadega perfluoroalküülrühma sisaldavad kompleksid, nende valmistamismeetod ja kasutamine | |
AU2002360531A1 (en) | Methods and compositions to treat cardiovascular disease using 1419, 58765 and 2201 | |
EP1689400A4 (en) | NEW COMPOUND, COMPOSITIONS THEREFOR, METHODS OF MAKING AND / OR PROCESSING | |
FR2820423B1 (fr) | Tartrate et phosphate de 3,4-diaminopyridine, compositions pharmaceutiques et utilisations |